Selected article for: "H1N1 virus and influenza influenza H1N1 virus"

Author: Menachery, Vineet D.; Schäfer, Alexandra; Burnum-Johnson, Kristin E.; Mitchell, Hugh D.; Eisfeld, Amie J.; Walters, Kevin B.; Nicora, Carrie D.; Purvine, Samuel O.; Casey, Cameron P.; Monroe, Matthew E.; Weitz, Karl K.; Stratton, Kelly G.; Webb-Robertson, Bobbie-Jo M.; Gralinski, Lisa E.; Metz, Thomas O.; Smith, Richard D.; Waters, Katrina M.; Sims, Amy C.; Kawaoka, Yoshihiro; Baric, Ralph S.
Title: MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
  • Document date: 2018_1_30
  • ID: 096gtdy5_3
    Snippet: Previously, our group used a combination of virologic, transcriptomic, and proteomic data to identify differences in the global type I IFN-stimulated gene (ISG) response across infections with A/influenza/California/04/2009 (H1N1; herein H1N1-09), A/influenza/ Significance Both highly pathogenic avian influenza virus and Middle East respiratory syndrome coronavirus (MERS-CoV) infections are characterized by severe disease and high mortality. The .....
    Document: Previously, our group used a combination of virologic, transcriptomic, and proteomic data to identify differences in the global type I IFN-stimulated gene (ISG) response across infections with A/influenza/California/04/2009 (H1N1; herein H1N1-09), A/influenza/ Significance Both highly pathogenic avian influenza virus and Middle East respiratory syndrome coronavirus (MERS-CoV) infections are characterized by severe disease and high mortality. The continued threat of their emergence from zoonotic populations underscores an important need to understand the dynamics of their infection. By comparing the host responses across other related respiratory virus infections, these studies have identified a common avenue used by MERS-CoV and A/influenza/Vietnam/ 1203/2004 (H5N1-VN1203) influenza to antagonize antigen presentation through epigenetic modulation. Overall, the use of cross-comparisons provides an additional approach to leverage systems biology data to identify key pathways and strategies used by viruses to subvert host immune responses and may be critical in developing both vaccines and therapeutic treatment.

    Search related documents:
    Co phrase search for related documents
    • antigen presentation and avian influenza virus: 1
    • antigen presentation and cross comparison: 1
    • antigen presentation and epigenetic modulation: 1
    • antigen presentation and high mortality: 1, 2, 3, 4, 5, 6, 7
    • antigen presentation and host immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • antigen presentation and host immune response subvert: 1
    • antigen presentation and host response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antigen presentation antagonize and epigenetic modulation: 1
    • avian influenza and continue threat: 1, 2, 3, 4, 5, 6
    • avian influenza and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • avian influenza and high mortality severe disease: 1, 2, 3, 4, 5, 6, 7, 8
    • avian influenza and host immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • avian influenza virus and continue threat: 1, 2, 3
    • avian influenza virus and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • avian influenza virus and high mortality severe disease: 1, 2, 3
    • avian influenza virus and host immune response: 1, 2, 3, 4, 5
    • continue threat and global type: 1
    • continue threat and high mortality: 1, 2, 3
    • continue threat and host immune response: 1, 2